...A. Overview: 2Q results reflect both environmental and ISRG-specific headwinds accompanied by underlying business strength. 1. 2. Procedures grew 14% YoverY, despite pressure from COVID-driven lockdowns in China, Co.'s second largest market. 3. Capital placement slowed from a year ago, due to a combination of factors described last qtr. 4. Overall pressure from COVID lockdowns impacted procedures modestly, while reduced trade-ins and supply chain timing impacted capital placements more significantly. 5. Leading indicator of the health of business, procedure demand, remains healthy. B. Procedures: Grew 14%, reflecting strength in US general surgery and solid growth extending beyond urology outside US. 1. 2. US procedure growth was led by bariatric surgery, cholecystectomy and colorectal procedures with continued growth in hernia repair. 3. In OUS markets, procedures grew 22%, despite COVID lockdown in China. a. Outside US, seeing strength in urology now accompanied by diversified growth...